MAZE
NA
$26.35
+$0.57(+2.21%)
48
Overall
60
Value
40
Tech
44
Quality
Market Cap
$1.35B
Volume
494.80K
52W Range
$9.73 - $53.65
Target Price
$62.55
Company Overview
| Mkt Cap | $1.35B | Price | $26.35 |
| Volume | 494.80K | Change | +2.21% |
| P/E Ratio | -10.3 | Open | $25.78 |
| Revenue | -- | Prev Close | $25.78 |
| Net Income | $-131.1M | 52W Range | $9.73 - $53.65 |
| Div Yield | N/A | Target | $62.55 |
| Overall | 48 | Value | 60 |
| Quality | 44 | Technical | 40 |
No chart data available
Latest News
J.P. Morgan Keeps Their Buy Rating on Maze Therapeutics, Inc. (MAZE)
TipRanks Auto-Generated Intelligence Newsdesk•4 days ago
Maze Therapeutics CFO Expands Role Amid Finance Leadership Change
TipRanks Auto-Generated Newsdesk•4 days ago
LifeSci Capital Remains a Buy on Maze Therapeutics, Inc. (MAZE)
TipRanks Auto-Generated Intelligence Newsdesk•11 days ago
Analysts Offer Insights on Healthcare Companies: Shoulder Innovations, Inc. (SI), Maze Therapeutics, Inc. (MAZE) and PACS Group Inc (PACS)
Brian Anderson•13 days ago
Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE) and Anixa Biosciences (ANIX)
Howard Kim•14 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MAZE | $26.35 | +2.2% | 494.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |